(NP (NP Enhancement/NN) (PP of/IN (NP (NP human/JJ immunodeficiency/NN virus/NN 1/CD replication/NN) (PP in/IN (NP monocytes/NNS)))) (PP by/IN (NP 1,25-dihydroxycholecalciferol/NN)) ./.)
(S (NP-SBJ (NP (NP Human/JJ immunodeficiency/NN virus/NN) (PRN -LRB-/-LRB- (NP HIV/NN) -RRB-/-RRB-)) (NP-COOD (NP expression/NN) and/CC (NP replication/NN))) (VP are/VBP (PP-PRD under/IN (NP tight/JJ regulatory/JJ control/NN))) ./.)
(S (NP-SBJ We/PRP) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ (NP 1,25-dihydroxycholecalciferol/NN) (PRN -LCB-/-LRB- (NP 1,25--LRB-OH-RRB-2D3/NN) -RCB-/-RRB-)) (VP enhances/VBZ (NP (NP the/DT replication/NN) (PP of/IN (NP (NP (ADJP-COOD (ADJP (NP monocyte-/NN) (ADJP *?*/-NONE-)) and/CC (ADJP lymphocyte-tropic/JJ)) strains/NNS) (PP of/IN (NP HIV-1/NN))))) (PP up/IN to/TO (ADVP 10,000-fold/RB)) (PP in/IN (NP-COOD (NP monocyte/NN cell/NN lines/NNS) ,/, (NP peripheral/JJ blood/NN monocytes/NNS) ,/, and/CC (NP unfractionated/JJ peripheral/JJ blood/NN mononuclear/JJ cells/NNS))))))) ./.)
(S (NP-SBJ 1,25-LRB-OH-RRB-2D3/NN) (VP is/VBZ (ADVP therefore/RB) (NP-PRD (NP one/CD) (PP of/IN (NP (NP the/DT (ADJP most/RBS potent/JJ) regulators/NNS) (PP of/IN (NP HIV-1/NN replication/NN)) (VP described/VBN (NP */-NONE-) (PP-TMP to/TO (NP date/NN))))))) ./.)
(S (NP-SBJ (NP Precursors/NNS) (PP of/IN (NP 1,25-LRB-OH-RRB-2D3/NN))) (VP enhance/VBP (NP HIV-1/NN replication/NN) (PP in/IN proportion/NN to/TO (NP (NP their/PRP$ affinity/NN) (PP for/IN (NP the/DT 1,25-LRB-OH-RRB-2D3/NN intracellular/JJ receptor/NN)))) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ 1,25-LRB-OH-RRB-2D3/NN) (VP influences/VBZ (NP HIV-1/NN replication/NN) (PP by/IN (NP (NP mechanisms/NNS) (VP involving/VBG (NP this/DT receptor/NN)))))))))) ./.)
(S (NP-SBJ These/DT studies/NNS) (VP may/MD (VP have/VB (NP (NP important/JJ implications/NNS) (PP for/IN (NP (NP the/DT design/NN) (PP of/IN (NP (NP effective/JJ therapy/NN) (PP of/IN (NP HIV-1/NN infection/NN))))))))) ./.)
